Reporting on Adverse Clinical Events

November 2015 in “ Clin-Alert ”

alopecia rivaroxaban minocycline clozapine hepatitis C treatments hypokalemia QTc interval drug-induced malignant arrhythmias clopidogrel herbal supplements tendinopathy ofloxacin otic drops hair loss Xarelto Minocin Clozaril low potassium heart rhythm problems Plavix herbal remedies ear drops

Studysummary Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on journals.sagepub.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Reporting on Adverse Clinical Events

March 2021 in “Clin-Alert”

This abstract lists a range of drugs and treatment agents like Abatacept, Amiodarone, and Remdesivir, but does not report any study results or findings.

research Rivaroxaban-induced hair loss

8 citations , August 2015 in “European Journal of Clinical Pharmacology”

This case report suggests that hair loss may be a potential adverse effect of rivaroxaban, though it is not listed in the product characteristics.

research Reporting on Adverse Clinical Events

October 2008 in “Clin-alert”

This abstract lists keywords related to various medications and therapies, but it does not provide new study results or findings.

Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System

research Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System

February 2026 in “Preprints.org”

This study analyzed data from the FDA Adverse Event Reporting System to evaluate cancer therapy–induced alopecia, finding that reporter type significantly affects signal detection, with docetaxel showing the highest disproportionate association overall, and vismodegib ranking highest among healthcare professional reports.

research Reporting on Adverse Clinical Events

July 2017 in “Clin-Alert”

Different medications can cause serious side effects in some people.